Purchases and Sales Made in Q3 2021 in Neurocrine Biosciences Inc (NBIX)
This table provides information about the institutional ownership of Neurocrine Biosciences Inc (NBIX) during Q3 2021. The information is specifically focused on institutions that hold shares of NEUROCRINE BIOSCIENCES INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 10, 2021
Q3 2021
|
Jupiter Asset Management LTD
|
SELL
|
- |
-37KClosed |
$3.19M - $3.66M
|
0
$0
|
|
|
Oct 19, 2021
Q3 2021
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-37.9K- 77.19% |
$3.26M - $3.75M
|
11.2K
$1.53M
|
|
|
Nov 15, 2021
Q3 2021
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-39.1K- 3.18% |
$3.37M - $3.87M
|
1.19M
$163M
|
|
|
Nov 02, 2021
Q3 2021
|
New York State Common Retirement Fund
|
SELL
|
- |
-39.5K- 15.77% |
$3.4M - $3.91M
|
211K
$28.8M
|
|
|
Nov 15, 2021
Q3 2021
|
Verition Fund Management LLC
Greenwich, CT |
SELL
|
- |
-42.7KClosed |
$3.68M - $4.23M
|
0
$0
|
|
|
Nov 12, 2021
Q3 2021
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-45.1KClosed |
$3.89M - $4.46M
|
0
$0
|
|
|
Nov 15, 2021
Q3 2021
|
Capital International, Inc.
Los Angeles, CA |
SELL
|
- |
-46.8K- 13.86% |
$4.03M - $4.63M
|
291K
$39.7M
|
|
|
Nov 09, 2021
Q3 2021
|
Barclays PLC
London, X0 |
SELL
|
- |
-47.6K- 23.46% |
$4.1M - $4.72M
|
155K
$21.2M
|
|
|
Nov 12, 2021
Q3 2021
|
Australian Super Pty LTD
|
SELL
|
- |
-71.5K- 34.47% |
$6.16M - $7.08M
|
136K
$18.5M
|
|
|
Nov 15, 2021
Q3 2021
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-82.5K- 22.03% |
$7.11M - $8.17M
|
292K
$39.9M
|
|
|
Nov 12, 2021
Q3 2021
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-87.8K- 23.96% |
$7.56M - $8.69M
|
279K
$38M
|
|
|
Nov 12, 2021
Q3 2021
|
Tekla Capital Management LLC
|
SELL
|
- |
-88.3K- 41.47% |
$7.61M - $8.74M
|
125K
$17M
|
|
|
Nov 12, 2021
Q3 2021
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-96.2K- 1.07% |
$8.29M - $9.52M
|
8.89M
$1.21B
|
|
|
Nov 03, 2021
Q3 2021
|
Van Eck Associates Corp
|
SELL
|
- |
-113KClosed |
$9.77M - $11.2M
|
0
$0
|
|
|
Nov 12, 2021
Q3 2021
|
Bank Of New York Mellon Corp
New York, NY |
SELL
|
- |
-114K- 5.64% |
$9.79M - $11.2M
|
1.9M
$260M
|
|
|
Nov 15, 2021
Q3 2021
|
Capital Bank & Trust CO
Irvine, CA |
SELL
|
- |
-120KClosed |
$10.3M - $11.9M
|
0
$0
|
|
|
Nov 15, 2021
Q3 2021
|
Polar Capital Holdings PLC
London, X0 |
SELL
|
- |
-134K- 81.82% |
$11.6M - $13.3M
|
29.8K
$4.07M
|
|
|
Nov 15, 2021
Q3 2021
|
Sofinnova Investments, Inc.
Menlo Park, CA |
SELL
|
- |
-203KClosed |
$17.5M - $20.1M
|
0
$0
|
|
|
Nov 15, 2021
Q3 2021
|
Pfm Health Sciences, LP
San Francisco, CA |
SELL
|
- |
-252K- 22.57% |
$21.7M - $24.9M
|
864K
$118M
|
|
|
Nov 15, 2021
Q3 2021
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-329K- 40.5% |
$28.3M - $32.6M
|
483K
$65.9M
|
|
|
Nov 01, 2021
Q3 2021
|
Nordea Investment Management Ab
Stockholm, V7 |
SELL
|
- |
-463K- 50.0% |
$39.9M - $45.8M
|
463K
$63.2M
|
|
|
Nov 15, 2021
Q3 2021
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-565K- 11.23% |
$48.7M - $55.9M
|
4.46M
$609M
|
|
|
Nov 15, 2021
Q3 2021
|
Arrow Mark Colorado Holdings LLC
Denver, CO |
SELL
|
- |
-572K- 95.65% |
$49.3M - $56.6M
|
26K
$3.55M
|
|
|
Nov 12, 2021
Q3 2021
|
Rockefeller Capital Management L.P.
New York, NY |
SELL
|
- |
-599K- 96.55% |
$51.6M - $59.3M
|
21.4K
$2.92M
|
|
|
Nov 15, 2021
Q3 2021
|
Capital International Investors
Los Angeles, CA |
SELL
|
- |
-669K- 59.95% |
$57.7M - $66.3M
|
447K
$61M
|
|
|
Nov 05, 2021
Q3 2021
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-733KClosed |
$63.2M - $72.6M
|
0
$0
|
|
|
Nov 15, 2021
Q3 2021
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-766K- 70.03% |
$66M - $75.9M
|
328K
$44.7M
|